Topical application of 0.005% latanoprost increases episcleral venous pressure in normal dogs
Susan Tsai(The Ohio State University Wexner Medical Center), Michael R. Robinson(Allergan (United States)), P. Elliott Miller(University of Wisconsin–Madison), Craig B Struble(Covance (United States)), Huajiang Li(Allergan (United States)), James A. Burke(Allergan (United States)), Alexandra Almazan(Allergan (Ireland)), Patrick M. Hughes(Allergan (United States)), Paul Conforti(Allergan (United States)), Susan S. Lee(Allergan (United States)), Susan J. Howard(Covance (United States))
Cited by 14
Related Papers
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
|BMC Cancer|2018|391
Plasma extracellular RNA profiles in healthy and cancer patients
|Scientific Reports|2016|294
Circulating giant macrophages as a potential biomarker of solid tumors
|Proceedings of the National Academy of Sciences|2014|281
Microwave Ablation for Hepatic Malignancies
|Annals of Surgery|2013|254